國家衛生研究院 NHRI:Item 3990099045/7569
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12500/13673 (91%)
造訪人次 : 2478497      線上人數 : 67
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/7569


    題名: Design, synthesis, and SAR studies of duel FLT-3 and Aurora kinase inhibitors
    作者: Hsieh, HP;Shiao, HY;Lin, WH;Hsu, JTA;Chao, YS
    貢獻者: Institute of Biotechnology and Pharmaceutical Research
    摘要: Aurora kinase and FMS-like Tyrosine Receptor 3 (FLT3) was found to associate with various cancers, including breast cancers, colorectal cancers, AML and so on. There are several Aurora kinase inhibitors and FLT3 inhibitors was developed and under clinical investigation. And no Aurora kinase inhibitors or FLT3 inhibitors currently approved for the treatment of cancers still.[p]We synthesized more than 1000 compounds mainly targeted at Aurora kinase. BPR1K871, a novel, potent, small-molecule inhibitor of multiple kinase showed potent in vitro activities for Aurora kinase A (IC50: 50 nM), FLT-3 (IC50: 29 nM) and at least other 17 kinases with low IC50 activities (nano molar range). In cell-based assay, BPR1K871also demonstrated its excellent anticancer activities (HCT116: 117 nM, MOLM-13: 2 nM, MIA Paca-2: 9 nM, Colo205: 33 nM). In the MOLM-13 xenograft animal studies, BPR1K871 suppressed tumor growth up to 98% at 3 mg/kg once a day for 10-day treatment by IV administration. The body weight loss is less than 5% during the dosing period. This non-clinical profile of BPR1K871 supports the further pre-clinical development.
    日期: 2012-03-25
    關聯: Abstracts of Papers - American Chemical Society. 2012 Mar 25;243:Article number 48-MEDI.
    Link to: http://abstracts.acs.org/chem/243nm/program/view.php?pub_num=48&par=MEDI
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000324503201706
    顯示於類別:[謝興邦] 會議論文/會議摘要
    [徐祖安] 會議論文/會議摘要
    [趙宇生(2002-2013)] 會議論文/會議摘要

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    ISI000324503201706.pdf81KbAdobe PDF579檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋